3 members of Congress have disclosed 11 trades in Nektar Therapeutics (NKTR) since 2015: 5 purchases worth about $40.00K and 6 sales worth about $48.00K. The most active was Ro Khanna, with 7 trades. The latest trade was made on Mar 6, 2020.
NKTR’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought NKTR, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ro KhannaD-CA | 7 | 4 | 3 | $32.00K | $24.00K | +$8.00K | -258.0% | Apr 3, 2018 | Mar 6, 2020 |
| 2 | Josh GottheimerD-NJ | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -267.0% | Jun 6, 2018 | Jun 21, 2018 |
| 3 | Eric SwalwellD-CA | 2 | 0 | 2 | $0.00 | $16.00K | -$16.00K | – | Jan 30, 2015 | Apr 1, 2015 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Buy | $1K–$15K | Mar 6, 2020 | Apr 20, 2020 | 45d | -87.5% | -240.4% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Sell | $1K–$15K | Oct 21, 2019 | Nov 12, 2019 | 22d | -86.1% | -236.8% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Buy | $1K–$15K | Sep 16, 2019 | Oct 16, 2019 | 30d | -88.4% | -239.0% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Buy | $1K–$15K | Jun 3, 2019 | Jul 11, 2019 | 38d | -92.8% | -266.7% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Sell | $1K–$15K | Jun 5, 2019 | Jul 11, 2019 | 36d | -92.7% | -258.5% | |
| Josh GottheimerD-NJ | NKTRNektar Therapeutics | Joint | Sell | $1K–$15K | Jun 21, 2018 | Oct 2, 2018 | 103d late | -95.6% | -269.9% | |
| Josh GottheimerD-NJ | NKTRNektar Therapeutics | Joint | Buy | $1K–$15K | Jun 6, 2018 | Oct 2, 2018 | 118d late | -95.9% | -267.0% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Sell | $1K–$15K | May 8, 2018 | Jun 8, 2018 | 31d | -96.8% | -278.6% | |
| Ro KhannaD-CA | NKTRNEKTAR THERAPEUTICS CMN | Spouse | Buy | $1K–$15K | Apr 3, 2018 | May 10, 2018 | 37d | -97.5% | -286.0% | |
| Eric SwalwellD-CA | NKTRNektar Therapeutics | Self | Sell | $1K–$15K | Apr 1, 2015 | Apr 7, 2015 | 6d | -77.2% | -342.9% | |
| Eric SwalwellD-CA | NKTRNEKTAn Therapeatics | Self | Sell | $1K–$15K | Jan 30, 2015 | Feb 27, 2015 | 28d | -83.2% | -360.3% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
3 members of Congress have disclosed 11 trades in Nektar Therapeutics (NKTR) since 2015: 5 purchases worth about $40.00K and 6 sales worth about $48.00K. The most active was Ro Khanna, with 7 trades. The latest trade was made on Mar 6, 2020. Most active: Ro Khanna (7), Josh Gottheimer (2), Eric Swalwell (2).
Since 2015 they have disclosed 5 purchases and 6 sales; by the midpoints of the disclosed ranges, about $40.00K bought and $48.00K sold, a net sale of $8.00K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded NKTR on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.